Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them

Geng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C

ACAAI 2023

Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management

Manning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU

ACAAI 2023

In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack Onset

Manning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M

HAEA National Summit 2023

Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey

Jones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M

HAEA National Summit 2023

Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative Study

Bukstein DA, Vibha Desai V, Goga L, Czado S, Brown M, Myers K, Audhya PK, Settipane RA, Busse PJ

HAEA National Summit 2023

Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks

Grumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T

EAACI 2023

Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxis

Betschel S, van Kooten S, Heckmann M, Danese S, Caballero T

EAACI 2023

Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacks

Valerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H

EAACI 2023

Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative Study

Bukstein D, Desai V, Goga L, Brown M, Settipane RA

EAC 2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

Craig T, Cribbs KA, Czado S

ISPOR 2023